Sean C. Dowdy, MD, chair, division of gynecologic surgery, department of obstetrics and gynecology, Mayo Clinic, discusses identified factors that cause prolonged delays between discovering an improved treatment or practice and the application of it.
Sean C. Dowdy, MD, chair, division of gynecologic surgery, department of obstetrics and gynecology, Mayo Clinic, discusses identified factors that cause prolonged delays between discovering an improved treatment or practice and the application of it.
Transcript
What factors have you identified that cause prolonged delays between discovering an improved treatment or practice and the application of it?
Well, that’s a problem for the entire medical system. There have been publications looking at what is the gap between knowledge and implementing
knowledge that’s learned in the lab, or just in clinical practice. An average gap is about 11 years, which is far too long. This needs to be something that we have in our culture of taking on new initiatives. So, that’s something that I think happens more in tertiary care centers and academic centers than in private practices.
That’s not always true; certainly, we have some private practitioners who are very up on the latest techniques and management. But, in general, it takes far too long to implement things in the practice, and there’s just not a lot of great incentives to do that. It’s much easier for physicians just to do today what they did 20 years ago, but that’s obviously not optimal patients. So, I think we need better guidelines, we need better quality indicators, to determine who is providing good care for patients, and provide incentives to change our practice with time.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Phase 1 Study Identifies Casdatifan Dose With Promising Responses in Pretreated Clear Cell RCC
February 18th 2025Casdatifan targets a transcription factor that binds with other proteins to switch off the body’s anti-inflammatory mechanisms, empowering genes that promote tumor growth in clear cell renal cell carcinoma (RCC).
Read More